Skip to main content
OpenTrials

Clinical trial condition

Hypercholesterolemia

Explore clinical trials studying Hypercholesterolemia. Study availability and eligibility vary by location and protocol.

954 public trials 47 recruiting studies
Refine in advanced search Browse all conditions

Hypercholesterolemia trial results

Completed

A Phase III Confirmatory Study of K-877 (Pemafibrate) in Patients With Hypercholesterolemia and Statin Intolerance

NCT05923281

Conditions
Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations
  • Nakayama Clinic Aichi, Japan
  • Kohnodai Hospital, National Center for Global Health and Medicine Chiba, Japan
  • Tashiro Endocrinology Clinic Fukuoka, Japan
  • Central Japan International Medical Center Gifu, Japan
View all 22 locations
View Trial Details
Completed

Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary Syndrome

NCT04873934

Conditions
Acute Coronary Syndrome, Arterial Occlusive Diseases, Arteriosclerosis, +11 more
Locations
  • Northeast Arkansas Baptist Clinic Jonesboro, Arkansas, United States
  • Central Cardiology Medical Center Bakersfield, California, United States
  • The Heart Group Cardiovascular Associates Inc Fresno, California, United States
  • Mission Heritage Medical Group Mission Viejo, California, United States
View all 88 locations
View Trial Details
Completed

Efficacy and Safety of Inclisiran as Monotherapy in Patients With Primary Hypercholesterolemia Not Receiving Lipid-lowering Therapy.

NCT05763875

Conditions
Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations
  • Parkway Medical Center Birmingham, Alabama, United States
  • SEC Clinical Research Dothan, Alabama, United States
  • Hillcrest Medical Research DeLand, Florida, United States
  • ClinCloud Maitland, Florida, United States
View all 42 locations
View Trial Details
Completed

Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies

NCT06005597

Conditions
ASCVD, Arterial Occlusive Diseases, Arteriosclerosis, +17 more
Locations
  • East Valley Diabetes & Endocrinology Gilbert, Arizona, United States
  • Jacksonville Center for Clinical Research Jacksonville, Florida, United States
  • Progressive Medical Research Port Orange, Florida, United States
  • Centricity Research - Columbus Columbus, Georgia, United States
View all 45 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and the Safety of Single Pill Combination (SPC) Ezetimibe/Rosuvastatin in Chinese Adult Patients With Primary Hypercholesterolemia Not Adequately Controlled on Statin Therapy

NCT04669041

Conditions
Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations
  • Investigational Site Number :1560033 Baotou, China
  • Investigational Site Number :1560001 Beijing, China
  • Investigational Site Number :1560068 Beijing, China
  • Investigational Site Number :1560021 Beijing, China
View all 40 locations
View Trial Details
Completed

Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies

NCT05142722

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +17 more
Locations
  • Pinnacle Research Group Anniston, Alabama, United States
  • Central Alabama Research Birmingham, Alabama, United States
  • Synexus Clinical Research US, Inc. / Simon Williamson Clinic, PC Birmingham, Alabama, United States
  • The Center for Clinical Trials, Inc Saraland, Alabama, United States
View all 181 locations
View Trial Details

Related conditions